Aleksandra Popović

MedicineBiochemistry, Genetics and Molecular BiologyEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Tumor Mutational Burden, Toxicity, and Response of Immune Checkpoint Inhibitors Targeting PD(L)1, CTLA-4, and Combination: A Meta-regression Analysis”.

Tumor Mutational Burden, Toxicity, and Response of Immune Checkpoint Inhibitors Targeting PD(L)1, CTLA-4, and Combination: A Meta-regression Analysis

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0458

N/A

0DataRank · unranked

109 citations

Su Jin Lim, Aleksandra Popović, Nilofer S. Azad, Daniel A. Laheru, Lei Zheng +4 more

Integrated immunological analysis of a successful conversion of locally advanced hepatocellular carcinoma to resectability with neoadjuvant therapy

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-000932

N/A

0DataRank · unranked

24 citations

Gaurav Sharma, Qingfeng Zhu, Genevieve L. Stein-O’Brien, Jennifer N. Durham, Robert A. Anders +8 more

Feasibility and efficacy of neoadjuvant cabozantinib and nivolumab in patients with borderline resectable or locally advanced hepatocellular carcinoma (HCC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.335

N/A

0DataRank · unranked

22 citations

Qingfeng Zhu, Jennifer N. Durham, Nicole Groß, Soren Charmsaz, James M. Leatherman +14 more